Literature DB >> 11199365

Probiotic therapy fails to improve gut permeability in a hapten model of colitis.

R J Kennedy1, M Hoper, K Deodhar, S J Kirk, K R Gardiner.   

Abstract

BACKGROUND: Studies in clinical and experimental inflammatory bowel disease (IBD) have shown disturbances in intestinal bacterial flora with an increase in potentially pathogenic and a decrease in protective organisms. It was hypothesized that Lactobacillus plantarum species 299 (LP299), a probiotic, would ameliorate colitis and improve intestinal permeability in experimental colitis. This study investigated the effect of LP299 in the trinitrobenzenesulfonic acid/ethanol (TNBS/E) rat model of colitis.
METHODS: Twelve week old male Wistar rats were randomized to receive rectal instillates of either TNBS/E (n = 48) or saline (n = 16). For the next 7 days the animals were gavaged with 2.5 ml of oat fibre suspension containing 10(9) colony forming units (CFU) of LP299 (LP299/OF), oat fibre suspension alone (OF) or no treatment. At the end of the experiment rats received radiolabelled polyethylene glycol and urine was collected for 24 h to assess permeability. Animals were then anaesthetized and colons were harvested for colon macroscopic scoring (CMS).
RESULTS: TNBS/E per rectum resulted in a greater CMS (P < 0.001) and gut permeability (P = 0.006) than saline. Administration of LP299/OF or oat fibre alone did not result in a reduction in CMS or gut permeability when compared to colitic controls.
CONCLUSIONS: LP299/OF, when administered after TNBS instillation, does not reduce the severity of colitis or improve gut permeability in this hapten model of colitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11199365     DOI: 10.1080/003655200453601

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

1.  Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998.

Authors:  R Salupere
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

Review 3.  Lactobacillus plantarum and Its Probiotic and Food Potentialities.

Authors:  Hamza Ait Seddik; Farida Bendali; Frédérique Gancel; Ismail Fliss; Giuseppe Spano; Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

Review 4.  Nutritional protective mechanisms against gut inflammation.

Authors:  Monica Viladomiu; Raquel Hontecillas; Lijuan Yuan; Pinyi Lu; Josep Bassaganya-Riera
Journal:  J Nutr Biochem       Date:  2013-03-27       Impact factor: 6.048

5.  Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld; John McRorie
Journal:  Dig Dis Sci       Date:  2011-05-12       Impact factor: 3.199

6.  Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.

Authors:  M Llopis; M Antolín; F Guarner; A Salas; J-R Malagelada
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

7.  Probiotics for maintenance of remission in ulcerative colitis.

Authors:  Zipporah Iheozor-Ejiofor; Lakhbir Kaur; Morris Gordon; Patricia Anne Baines; Vasiliki Sinopoulou; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

8.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

9.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.

Authors:  Erika Mileti; Gianluca Matteoli; Iliyan D Iliev; Maria Rescigno
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

Review 10.  Probiotics and human health: a clinical perspective.

Authors:  H S Gill; F Guarner
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.